產(chǎn)品名稱 MHY 553 - NSC 33005
產(chǎn)品貨號 Axon 2814 CAS [6265-56-1] MF C13H9NO2SMW 243.28 Purity: 98% Soluble in DMSO Description MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis, in part by increasing β-oxidation signaling and decreasing inflammation in the liver. Potential pharmaceutical agent for treating hepatic steatosis in aging. Keywords: MHY 553 | supplier | PPARα agonist? | NSC 33005 | MHY553 | MHY-553 | NSC33005 | NSC-33005 | CAS [6265-56-1] | Metabolism | PPAR | Agonist | Receptors | Hepatic steatosis
產(chǎn)品價格 現(xiàn)貨詢價，電話：010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

MHY 553 - NSC 33005

Based on 9 reference(s) in Google Scholar 8 10 9

Axon 2814

CAS [6265-56-1]

MF C13H9NO2S
MW 243.28

  • Purity: 98%
  • Soluble in DMSO

MHY 553

Description

MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis, in part by increasing β-oxidation signaling and decreasing inflammation in the liver. Potential pharmaceutical agent for treating hepatic steatosis in aging.

Keywords: MHY 553 | supplier | PPARα agonist? | NSC 33005 | MHY553 | MHY-553 | NSC33005 | NSC-33005 | CAS [6265-56-1] | Metabolism | PPAR | Agonist | Receptors | Hepatic steatosis?

產(chǎn)品資料